Guardian Research Network® and ThinkGenetic Announce Collaborative Partnership to Accelerate Diagnosis and Treatment Options for Patients with Genetic Diseases and Inherited Predisposition to Cancer Joint effort recognizes combined missions to support… CONTINUE
ThinkGenetic Announces Integration of Innovative Diagnostic Aid in Takeda Pilot Awareness Initiative
Pilot program brings genetic tools and education to patients searching for answers tied to their chronic medical conditions in Taiwan, Mexico, Argentina, Brazil, Turkey, and Russia BOSTON, December 15, 2020… CONTINUE
ThinkGenetic Partners with Genome Medical
New Partnership Strengthens ThinkGenetic’s Continued Effort to Reduce Time to Diagnosis In an influential move for the genetics community, ThinkGenetic (ThinkGenetic.com) and Genome Medical (GenomeMedical.com), a nationwide specialty medical practice… CONTINUE
Bringing Light to Rare Neuromuscular Disease with New ThinkGenetic Advocacy Partnership
Neuromuscular Disease Foundation Partners with ThinkGenetic to Boost Awareness In a move that will broaden the reach of valuable resources available to those living with GNE Myopathy (or HIBM), the… CONTINUE
ThinkGenetic Boosts Kabuki Syndrome Awareness by Recognizing Advocacy Partnership with All Things Kabuki
All Things Kabuki became one of the earliest ThinkGenetic Advocacy Partners when it joined the Advocacy Partner Program in September 2016. Today, we mark Kabuki Syndrome Awareness Day (#kabukisyndrome) by… CONTINUE
Canadian Fabry Association Partners with ThinkGenetic To Broaden Support for Patients with Fabry Disease
The Canadian Fabry Association (CFA), a non-profit organization raising awareness and educating the public about Fabry disease, has joined ThinkGenetic’s Advocacy Partner program. The CFA is committed to improving the… CONTINUE
Care Day for Hereditary ATTR Amyloidosis Comes to Albany
Alnylam and ThinkGenetic are looking forward to another successful Care Day Event for hATTR amyloidosis in Albany, NY on the 12 of August. Come learn about topics relating to hATTR amyloidosis including: Disease… CONTINUE
ThinkGenetic Signs First International Advocacy Partner
France based support group, Cutis Laxa Internationale, becomes first International ThinkGenetic Advocacy Partner Cutis Laxa Internationale became an official ThinkGenetic Advocacy Partner today, the first advocacy partner based outside the… CONTINUE
ThinkGenetic Joins Forces with C22C
ThinkGenetic is pleased to announce the advocacy partnership with Chromosome 22 Central, Inc., also known as C22C. Chromosome 22 Central is a parent powered support organization founded in 1997 to… CONTINUE
New Partnership with Genetic Alliance Helps Expands Healthcare Resources for Genetic Disease Patients Online
Largest Non-Profit Genetic Health Advocacy Organization, Genetic Alliance, Joins in Partnership with ThinkGenetic to Empower Patients In a time when “genetics”, “genomes”, and “genes” are becoming a daily topic of… CONTINUE
Partner Agreement with FSIG will Help Get Answers to the Fabry Disease Community
In a showing of mutual respect and appreciation, Fabry Support & Information Group (FSIG) signed an Advocate Partnership Agreement with ThinkGenetic. “We are truly thrilled to partner with ThinkGenetic and… CONTINUE